The FIT Test Is Yearly — Here's Why

Why Yearly, Not Every Few Years

A fecal immunochemical test, or FIT, is recommended once every year for average-risk adults using it as their colorectal cancer screening method — not once every three years like some stool-DNA tests, and not once a decade like a colonoscopy 1Ref 1Rex DK, Boland CR, Dominitz JA, et al. (U.S. Multi-Society Task Force on Colorectal Cancer) (2017).Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.Supports that annual FIT and colonoscopy every ten years are ranked as first-tier screening options, with stool-DNA testing and CT colonography as second-tier, establishing why the intervals differ.. That yearly cadence isn't arbitrary; it's built directly into how the test is designed to work.

FIT is a program, not a single event. A single FIT misses some cancers and precancerous polyps that a colonoscopy would catch directly, so its real-world protection comes from testing again next year, and the year after that, catching on a repeat round whatever a single test missed. Skip years, and you've quietly opted out of the design that makes FIT an acceptable colonoscopy alternative in the first place.

What FIT Accuracy Numbers Actually Mean

A single FIT has pooled sensitivity around 79% for colorectal cancer and specificity around 94%, meaning it correctly flags roughly four out of five cancers present at the time of testing and correctly clears the large majority of people who don't have one 2Ref 2Lee JK, Liles EG, Bent S, Levin TR, Corley DA (2014).Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis.Supports the quantitative sensitivity (~79%) and specificity (~94%) of a single FIT, explaining why annual repetition is needed to build cumulative protection.. Those numbers sound solid until you consider what the missing one-in-five means for someone using FIT just once and calling it done.

Annual testing is the corrective. A cancer that a FIT misses this year, because it happened to bleed too little to detect on that particular stool sample, has another chance to be caught next year, and the year after — repeated low-friction testing compounds into meaningfully better protection than the single-test numbers alone suggest. This is also why fecal immunochemical test performance is best understood as a question about a testing program, not a one-time verdict.

What Happens If You Skip a Year

Missing one year doesn't erase your prior negative results, but it does open a gap during which a new polyp or early cancer has more time to develop and grow before anything catches it. The entire premise behind FIT's yearly interval is that testing happens again before a slow-growing lesion has much time to progress — stretch the interval to two or three years informally, and you've effectively adopted a different, less-studied screening schedule without meaning to.

There's no clinical rescue mechanism that automatically flags a missed year; it depends on you or your primary-care office tracking it. Setting a yearly reminder tied to a fixed point — a birthday, a New Year's checkup — is a low-effort way to keep the program's actual protection intact rather than drifting toward whenever it's convenient.

Life events are the most common reason a year slips by unnoticed: switching insurance plans, changing primary-care practices, or simply not receiving a kit in the mail because a prior address is still on file. None of these are your fault in any meaningful sense, but none of them pause the underlying biology either, which is exactly why building your own reminder is more reliable than assuming a system will catch it for you.

Does Insurance Cover a FIT Every Year?

Yes, for most people. The ACA requires private insurers and Medicare to cover USPSTF-recommended colorectal cancer screening — which includes an annual FIT for average-risk adults — without patient cost-sharing, meaning no copay, coinsurance, or deductible applied to the test itself when it's used as recommended 3Ref 3American Cancer Society (2024).Insurance Coverage for Colorectal Cancer Screening.Supports that the ACA requires no-cost-sharing coverage of an annual FIT as recommended screening, and that a follow-up colonoscopy after a positive stool test is covered as screening rather than diagnostic care..

If you're enrolled in a Medicare Advantage plan rather than Original Medicare, that protection still applies: Medicare Advantage plans are required to cover at least the same benefits as Original Medicare, including preventive screenings like an annual FIT 4Ref 4Centers for Medicare & Medicaid Services (2024).Medicare Advantage & other health plans.Supports that Medicare Advantage plans must cover at least the same benefits as Original Medicare, which extends the annual FIT coverage protection to Medicare Advantage enrollees.. Medicaid coverage varies more by state, so it's worth confirming directly with your plan if that's your coverage.

The one place billing complexity creeps back in is if your FIT comes back positive. The follow-up colonoscopy that a positive FIT triggers is still generally covered as screening, not as a separate diagnostic charge, under the same ACA screening protections 3Ref 3American Cancer Society (2024).Insurance Coverage for Colorectal Cancer Screening.Supports that the ACA requires no-cost-sharing coverage of an annual FIT as recommended screening, and that a follow-up colonoscopy after a positive stool test is covered as screening rather than diagnostic care..

FIT vs Cologuard vs Colonoscopy: Why the Intervals Differ

The three main colorectal cancer screening options carry different intervals because they trade off differently between how well one single test performs and how tolerable it is to do again and again. The U.S. Multi-Society Task Force ranks colonoscopy every ten years and annual FIT as first-tier options, with stool-DNA tests like Cologuard and CT colonography as second-tier alternatives 1Ref 1Rex DK, Boland CR, Dominitz JA, et al. (U.S. Multi-Society Task Force on Colorectal Cancer) (2017).Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.Supports that annual FIT and colonoscopy every ten years are ranked as first-tier screening options, with stool-DNA testing and CT colonography as second-tier, establishing why the intervals differ..

A colonoscopy directly visualizes the colon and can both find and remove a polyp in the same visit, which is why its interval can stretch to a decade. FIT sees none of that directly — it only detects blood chemistry in stool — so it needs to run every year to build up comparable protection over time. Fit vs cologuard is its own detailed comparison, since Cologuard's different detection method and specificity trade-offs change that calculus again. Fobt vs fit is a related but distinct comparison, covering the older guaiac-based stool test FIT was designed to replace.

None of this makes one option objectively better for every person. A colonoscopy trades a once-a-decade procedure with sedation and a bowel prep for a test you only have to sit through once every ten years, while FIT trades away that convenience for a once-a-year, no-sedation test done entirely at home. Choosing between them is a genuine preference decision to have with a primary-care clinician, not a question with one universally correct answer.

If This Year's FIT Comes Back Positive

A positive FIT is not a cancer diagnosis. It means blood was detected in the stool sample, and the next step is a colonoscopy to find out why — not a repeat FIT, and not a wait-and-see approach 3Ref 3American Cancer Society (2024).Insurance Coverage for Colorectal Cancer Screening.Supports that the ACA requires no-cost-sharing coverage of an annual FIT as recommended screening, and that a follow-up colonoscopy after a positive stool test is covered as screening rather than diagnostic care.. Causes range from hemorrhoids and minor GI irritation to polyps and, less commonly, cancer, and only a colonoscopy can tell those apart.

That follow-up colonoscopy is treated as a continuation of the screening process for billing purposes under current ACA rules, not as a new diagnostic workup starting from scratch 3Ref 3American Cancer Society (2024).Insurance Coverage for Colorectal Cancer Screening.Supports that the ACA requires no-cost-sharing coverage of an annual FIT as recommended screening, and that a follow-up colonoscopy after a positive stool test is covered as screening rather than diagnostic care.. Scheduling it promptly matters more than the specific week it happens in — the point of the whole FIT program is catching something early, and that only works if a positive result gets acted on rather than sat with until next year's test.